Filter
259
Text search:
drug
manufacturing
Featured
Recommendations
24
New Publications
54
Language
Document type
No document type
107
Studies & Reports
59
Guidelines
50
Strategic & Response Plan
17
Manuals
13
Fact sheets
6
Situation Updates
3
Resource Platforms
2
Training Material
1
Brochures
1
Countries / Regions
Ghana
14
Global
13
Kenya
12
India
8
Ethiopia
7
Uganda
6
Zimbabwe
6
South Africa
6
Zambia
5
Tanzania
5
Botswana
5
Western and Central Europe
5
Nigeria
4
Malawi
4
South–East Asia Region
4
Africa
4
Philippines
3
Nepal
3
Eastern Europe
3
Sierra Leone
2
Senegal
2
Rwanda
2
Sudan
2
Latin America and the Carribbean
2
Congo, Democratic Republic of
1
Cameroon
1
Pakistan
1
Syria
1
Cambodia
1
Indonesia
1
Bangladesh
1
Mozambique
1
Ukraine
1
Lesotho
1
Asia
1
Tajikistan
1
Russia
1
Moldova
1
Uzbekistan
1
Vietnam
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
100
Clinical Guidelines
17
Pharmacy & Technologies
14
Key Resources
10
Public Health
8
Women & Child Health
3
Capacity Building
2
Toolboxes
AMR
31
COVID-19
30
Pharmacy
28
HIV
18
TB
18
Mental Health
12
Planetary Health
10
Malaria
5
NTDs
4
NCDs
4
Ebola & Marburg
3
Conflict
3
Rapid Response
3
Specific Hazards
3
Global Health Education
3
Caregiver
3
Health Financing Toolbox
3
Natural Hazards
2
2.0 Rapid Response
2
Disability
1
Cholera
1
Polio
1
Refugee
1
Recommendations for step-wise implementation
The Quadripartite Organizations – the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Organisation for Animal Health (WOAH, founded as OIE), and the World Health Organization (WHO) – collaborate to drive the change and tra
...
In many countries neonatal tetanus is responsible for half of all neonatal deaths due to vaccine-preventable diseases and for almost 14% of al¡ infant deaths. It is estimated that in the 1970s more than 10,000 newborns died annually from neonatal tetanus in the Americas. Neonatal tetanus is prevent
...
This report aims to support countries in the necessary transition toward healthier, more sustainable diets by integrating biodiversity in food-based interventions to support nutrition and health. It is intended to help guide decision-makers in the health, nutrition and other sectors, to:
Consider
...
Health ministries currently lack effective tools for monitoring and evaluation of schistosomiasis control programmes. Egg detection can be used, but the cost, challenges of obtaining samples, and the need for trained personnel and equipment limit the frequency of monitoring. The purpose of this TPP
...
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not
...
The South African WHO Country Cooperation Strategy (CCS) 2023–2027 focuses on four key strategic priorities based on the country’s health needs and disease epidemiology, while also considering the need for building resilient health systems for UHC and health security in the post pandemic period.
...
Climate change is damaging human health now and is projected to have a greater impact in the future. Low- and middle-income countries are seeing the worst effects as they are most vulnerable to climate shifts and least able to adapt given weak health systems and poor infrastructure. Low-carbon appro
...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance
...
Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force
